Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Nucleic Acid Therapeutics
|
October 18, 2018
Inferring Half-Lives at the Effect Site of Oligonucleotide Drugs
Rasmus Jansson-Löfmark, Peter Gennemark
Clinical Pharmacology and Therapeutics
|
April 11, 2020
Does In Vitro Potency Predict Clinically Efficacious Concentrations?
Rasmus Jansson-Löfmark, Stephan Hjorth, Johan Gabrielsson
Methods in Molecular Biology (Clifton, N.J.)
|
August 15, 2019
ADME: Assessing Pharmacokinetic-Pharmacodynamic Parameters of Oligonucleotides
Rasmus Jansson-Löfmark, Christine Ahlström, Peter Gennemark
Clinical Pharmacokinetics
|
February 9, 2026
Systemic Pharmacokinetic Principles of Therapeutic Peptides
Pär Nordell, Rasmus Jansson-Löfmark, Peter Gennemark
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 13, 2021
Comparisons of basic target-mediated drug disposition (TMDD) and ligand facilitated target removal (LFTR)
Lambertus A Peletier, Rasmus Jansson-Löfmark, Johan Gabrielsson
Journal of Pharmacokinetics and Pharmacodynamics
|
November 4, 2010
Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions
Christine Ahlström, Lambertus A Peletier, Rasmus Jansson-Löfmark, et al.
The AAPS Journal
|
September 4, 2025
Pharmacokinetics of Racemic Eflornithine in Human Plasma and Cerebrospinal Fluid: Clinical Perspectives for L-eflornithine Against Human African Trypanosomiasis
Mikael Boberg, Kesara Na-Bangchang, Michael Ashton, et al.
Drug Discovery Today
|
June 1, 2018
Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development
Shalini Andersson, Madeleine Antonsson, Marie Elebring, et al.
Drug Discovery Today
|
December 12, 2018
Corrigendum to 'Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development' Drug Discovery Today 23 (2018) 1733-1745
Shalini Andersson, Madeleine Antonsson, Marie Elebring, et al.
ACS Omega
|
September 28, 2020
Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l-Eflornithine
Mikael Boberg, Anna C Jonson, Hanna Leek, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Nucleic Acid Therapeutics
|
October 18, 2018
Inferring Half-Lives at the Effect Site of Oligonucleotide Drugs
Rasmus Jansson-Löfmark, Peter Gennemark
Clinical Pharmacology and Therapeutics
|
April 11, 2020
Does In Vitro Potency Predict Clinically Efficacious Concentrations?
Rasmus Jansson-Löfmark, Stephan Hjorth, Johan Gabrielsson
Methods in Molecular Biology (Clifton, N.J.)
|
August 15, 2019
ADME: Assessing Pharmacokinetic-Pharmacodynamic Parameters of Oligonucleotides
Rasmus Jansson-Löfmark, Christine Ahlström, Peter Gennemark
Clinical Pharmacokinetics
|
February 9, 2026
Systemic Pharmacokinetic Principles of Therapeutic Peptides
Pär Nordell, Rasmus Jansson-Löfmark, Peter Gennemark
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 13, 2021
Comparisons of basic target-mediated drug disposition (TMDD) and ligand facilitated target removal (LFTR)
Lambertus A Peletier, Rasmus Jansson-Löfmark, Johan Gabrielsson
Journal of Pharmacokinetics and Pharmacodynamics
|
November 4, 2010
Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions
Christine Ahlström, Lambertus A Peletier, Rasmus Jansson-Löfmark, et al.
The AAPS Journal
|
September 4, 2025
Pharmacokinetics of Racemic Eflornithine in Human Plasma and Cerebrospinal Fluid: Clinical Perspectives for L-eflornithine Against Human African Trypanosomiasis
Mikael Boberg, Kesara Na-Bangchang, Michael Ashton, et al.
Drug Discovery Today
|
June 1, 2018
Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development
Shalini Andersson, Madeleine Antonsson, Marie Elebring, et al.
Drug Discovery Today
|
December 12, 2018
Corrigendum to 'Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development' Drug Discovery Today 23 (2018) 1733-1745
Shalini Andersson, Madeleine Antonsson, Marie Elebring, et al.
ACS Omega
|
September 28, 2020
Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l-Eflornithine
Mikael Boberg, Anna C Jonson, Hanna Leek, et al.
Page
of 5